Literature DB >> 8201676

Development of a mouse model for nonbacterial prostatitis.

D W Keetch1, P Humphrey, T L Ratliff.   

Abstract

Nonbacterial prostatitis is a common clinical entity which is often difficult to diagnose and treat. Little is known with regard to the etiology and pathogenesis of this disease process. To develop an animal model and characterize the immune parameters of nonbacterial prostatitis, we harvested the prostates from SJL, AJ, Balb/c, C57bl/6 and C57bl/6 lpr mice. These prostates were homogenized and injected into syngeneic mice. Controls were injected with Freund's complete adjuvant only. Mice from each group were sacrificed 30 days after injection, and the prostates were harvested. Prostatic tissue was examined histologically for degree of inflammation. None of the Balb/c mice exhibited prostatic inflammation. The SJL and AJ mice exhibited varying degrees of prostatic inflammation. All of the C57bl/6 mice were found to have lymphocytic infiltration of the stroma and periglandular region. The C57bl/6 lpr mice did not appear to be more susceptible than the parental strain. Adoptive transfer studies demonstrated the prostatic inflammation to be at least in part immune mediated. We conclude that injection of syngenic prostate antigen induces prostatic inflammation similar to clinical nonbacterial prostatitis. Nonbacterial prostatitis may be an autoimmune process.

Entities:  

Mesh:

Year:  1994        PMID: 8201676     DOI: 10.1016/s0022-5347(17)32871-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  The picture of the prostatic lymphokine network is becoming increasingly complex.

Authors:  Georg E Steiner; Bob Djavan; Gero Kramer; Alessandra Handisurya; Martin Newman; Chung Lee; Michael Marberger
Journal:  Rev Urol       Date:  2002

2.  Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2.

Authors:  Yijie Cheng; Yanfang Cao; Awais Ullah Ihsan; Farhan Ullah Khan; Xue Li; Dianyou Xie; Xingxing Cui; Wenlu Wang; Ziwei Liu; Cunyu Li; Khalil Ali Ahmad; Kiganda Raymond Sembatya; Reyaj Mikrani; Xiaohui Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

3.  Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

Authors:  C Wei; R A Willis; B R Tilton; R J Looney; E M Lord; R K Barth; J G Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Histopathological classification criteria of rat model of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Xianjin Wang; Shan Zhong; Tianyuan Xu; Leilei Xia; Xiaohua Zhang; Zhaowei Zhu; Minguang Zhang; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-11-20       Impact factor: 2.370

Review 5.  Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy.

Authors:  Yuqian Liu; Junaid Wazir; Meng Tang; Rahat Ullah; Yueting Chen; Tingting Chen; Xiaohui Zhou
Journal:  Int Urol Nephrol       Date:  2020-11-16       Impact factor: 2.370

Review 6.  Mechanisms in prostatitis/chronic pelvic pain syndrome.

Authors:  Michel A Pontari; Michael R Ruggieri
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

7.  Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation.

Authors:  Isabella M Fuentes; Angela N Pierce; Pierce T O'Neil; Julie A Christianson
Journal:  J Vis Exp       Date:  2015-08-13       Impact factor: 1.355

8.  Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis.

Authors:  M Maccioni; V E Rivero; C M Riera
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 9.  Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Michel A Pontari
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 10.  Prostatitis.

Authors:  G J Domingue; W J Hellstrom
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.